HomeTagsAscletis

Ascletis

Biotechnology

Ascletis Announces Submission of Marketing Authorization Applications for Ritonavir in Multiple European Countries

PR Newswire - February 14, 2022

Ascletis Pharma Inc. announces that it has submitted marketing authorization applications for ritonavir (100 mg film-coated tablet) in Germany, France, Ireland and United Kingdom...

Biotechnology

Ascletis Announces U.S. IND Approval of Oral PD-L1 Small Molecule Inhibitor ASC61 for Treatment of Advanced Solid Tumors

PR Newswire - February 7, 2022

Ascletis Pharma Inc. announces the approval of the Investigational New Drug (IND) application by U.S. Food and Drug Administration (FDA) for in-house developed oral...